1.
J Med Chem
; 50(5): 897-900, 2007 Mar 08.
Article
in English
| MEDLINE
| ID: mdl-17269759
ABSTRACT
Optimization of a pyrrolidine-based template using structure-based design and physicochemical considerations has provided a development candidate 20b (3082) with submicromolar potency in the HCV replicon and good pharmacokinetic properties.